Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kennedy

Showing results (1071-1080 of 1,151) with videos related to

Pageof 116
Sort By:
British Journal of Pharmacology|July 2, 2010
WAY-318068: a novel, potent and selective noradrenaline re-uptake inhibitor with activity in rodent models of pain and depressionG T Whiteside, J M Dwyer, J E Harrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2019
Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c TrialPriyanka Sharma, William E Barlow, Andrew K Godwin, et al.
Nature|May 3, 2019
CD8<sup>+</sup> T cells regulate tumour ferroptosis during cancer immunotherapyWeimin Wang, Michael Green, Jae Eun Choi, et al.
Pain|September 20, 2016
Cross-centre replication of suppressed burrowing behaviour as an ethologically relevant pain outcome measure in the rat: a prospective multicentre studyRachel Wodarski, Ada Delaney, Camilla Ultenius, et al.
Pain|November 8, 2016
Cross-centre replication of suppressed burrowing behaviour as an ethologically relevant pain outcome measure in the rat: a prospective multicentre studyRachel Wodarski, Ada Delaney, Camilla Ultenius, et al.
ESMO Open|October 12, 2024
Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trialE Scanlon, A Lavery, M Albraikat, et al.
Journal of the National Cancer Institute|January 10, 2014
Identification and validation of an anthracycline/cyclophosphamide-based chemotherapy response assay in breast cancerJude M Mulligan, Laura A Hill, Steve Deharo, et al.
Journal of Medicinal Chemistry|March 15, 2021
One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRASJuergen Ramharter, Dirk Kessler, Peter Ettmayer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapyS Jain, C A Lyons, S M Walker, et al.
European Urology|April 15, 2017
Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic BiologySteven M Walker, Laura A Knight, Andrena M McCavigan, et al.
Pageof 116

Showing results (1071-1080 of 1,151) with videos related to

Sort By:
Pageof 116
British Journal of Pharmacology|July 2, 2010
WAY-318068: a novel, potent and selective noradrenaline re-uptake inhibitor with activity in rodent models of pain and depressionG T Whiteside, J M Dwyer, J E Harrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2019
Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c TrialPriyanka Sharma, William E Barlow, Andrew K Godwin, et al.
Nature|May 3, 2019
CD8<sup>+</sup> T cells regulate tumour ferroptosis during cancer immunotherapyWeimin Wang, Michael Green, Jae Eun Choi, et al.
Pain|September 20, 2016
Cross-centre replication of suppressed burrowing behaviour as an ethologically relevant pain outcome measure in the rat: a prospective multicentre studyRachel Wodarski, Ada Delaney, Camilla Ultenius, et al.
Pain|November 8, 2016
Cross-centre replication of suppressed burrowing behaviour as an ethologically relevant pain outcome measure in the rat: a prospective multicentre studyRachel Wodarski, Ada Delaney, Camilla Ultenius, et al.
ESMO Open|October 12, 2024
Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trialE Scanlon, A Lavery, M Albraikat, et al.
Journal of the National Cancer Institute|January 10, 2014
Identification and validation of an anthracycline/cyclophosphamide-based chemotherapy response assay in breast cancerJude M Mulligan, Laura A Hill, Steve Deharo, et al.
Journal of Medicinal Chemistry|March 15, 2021
One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRASJuergen Ramharter, Dirk Kessler, Peter Ettmayer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapyS Jain, C A Lyons, S M Walker, et al.
European Urology|April 15, 2017
Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic BiologySteven M Walker, Laura A Knight, Andrena M McCavigan, et al.
Pageof 116